Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure
- Resource Type
- Correspondence
- Source
- In
European Journal of Internal Medicine September 2022 103:111-112 - Subject
- Language
- ISSN
- 0953-6205